We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Encourages Central IRBs; SACHRP Calls for More Talks
FDA Encourages Central IRBs; SACHRP Calls for More Talks
March 22, 2006
The FDA is encouraging institutions to consider using centralized institutional review boards (IRBs) to coordinate the actions of multiple IRBs in multicenter clinical trials, according to new industry guidance.